Alternatives to Oncohost

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered platform personalizing and optimizing cancer patient monitoring and treatment.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Infiniplex offers a comprehensive cancer screening platform utilizing advanced AI and multi-omic analysis.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Leveraging the adaptive immune system to diagnose and treat disease.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

A medical platform connecting patients and physicians with genetic expertise.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Developing AI-driven technology for mental health treatments, focusing on PTSD.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

Sensifai desarrolla reconocimiento potenciado por IA, soluciones DeFi seguras y plataformas Web3 innovadoras.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Microbiome technology platform for developing novel therapeutics.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Deep learning-powered pathology analysis for personalized cancer management and treatment.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.

Medical device company developing advanced sensor technology for oncology treatment.

AI-powered platform enhancing surgical precision and patient outcomes through data-driven recommendations.